Implantable cardiac stimulator with rate-adaptive T-wave detection

• US 5,861,009 A
• Filed: 10/21/1997
• Issued: 01/19/1999
• Est. Priority Date: 10/21/1997
• Status: Expired due to Term

• Current Assignee: Intermedics Incorporated
• Original Assignee: Sulzer Intermedics, Inc. (Sulzer AG)
• Inventors: Cook, Douglas J., Armstrong, Randolph K., Vandegriff, Joseph W.
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): SCHAETZLE, KENNEDY
• Application Number:
  US08/955,411
• Time in Patent Office: 455 Days
• Field of Search: 607/17, 607/18-26, 607/4, 600/509
• US Class Current: 607/17
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/3704 Circuits specially adapted therefor, e.g. for sensitivity control
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

An implantable device for providing pacing and defibrillating stimuli to a heart, comprises: a power source, at least one electrode electrically connected to said power source, a sensor capable of providing data that can be used to determine a physiological pacing demand, and a control device. The control device controls the application of electrical stimuli to the heart. The control device calculates an adjusted pacing interval based on said demand, calculates an adjusted ventricular pace refractory period (VPRP_current) that is a function of said pacing interval, and calculates a T-wave monitoring window. The end time, and optionally the start time also, of the T-wave window is a function of the pacing interval. The control device is also capable of adjusting the sensitivity of an amplifier based on signals received during the T-wave window.

Claims

1. An implantable device for providing pacing and defibrillating stimuli to a heart, comprising:

a power source;

at least one electrode electrically connected to said power source;

a sensor capable of providing data that can be used to determine a physiological pacing demand; and

a control device, said control device controlling the application of electrical stimuli through said electrode, said control device calculating a physiological pacing demand based on said data, calculating an adjusted pacing interval based on said demand, calculating an adjusted ventricular pace refractory period (VPRP_current) that is a function of said pacing interval, and calculating the end time of a T-wave monitoring window, said end time being a function of said pacing interval and being less than said VPRP_current.

2. The implantable device according to claim 1 wherein said control device also calculates the start time of a T-wave monitoring window.

3. The implantable device according to claim 2 wherein said start time is a function of said pacing interval and is less than said end time.

4. The implantable device according to claim 2 wherein said start time is a constant.

5. The implantable device according to claim 1 wherein said VPRP_current is proportional to the difference between a baseline pacing interval and the adjusted pacing interval.

6. The implantable device according to claim 1, further including a detector that detects T-waves that occur before said end time.

7. The implantable device according to claim 6, further including an amplifier with an adjustable gain, wherein said gain is adjusted in response to changes in the amplitude of signals detected by said detector.

8. The implantable device according to claim 1 wherein said end time is a function of said VPRP_current.

9. A method for monitoring a heart, comprising:

(a) sensing data that can be used to determine a pacing demand;

(b) calculating an adjusted pacing interval based on the demand;

(c) calculating an adjusted ventricular pace refractory period (VPRP_current) that is a function of the pacing interval;

(d) calculating the end time of a T-wave monitoring window, the end time being a function of the pacing interval and being less than the VPRP_current ;

(e) providing the start time of the T-wave window; and

(f) monitoring electrical signals emitted by the heart during the period between the start time and the end time of the T-wave window.

10. The method according to claim 9 wherein the monitoring of step (f) is carried out so as to detect T-waves.

11. The method according to claim 9, further including the step of adjusting the gain of a signal amplifier in response to changes in the amplitude of signals detected during step (f).

12. The method according to claim 9, further including the step of controlling the application of electrical stimuli through the electrode so as to correspond to the adjusted pacing interval.

13. The method according to claim 9 wherein step (e) is carried out by calculating a start time that is a function of the adjusted pacing interval.

14. The method according to claim 9 wherein step (e) is carried out by calculating a start time that is a function of the end time.

15. A control device for an implantable cardioverter/defibrillator that is also capable of providing pacing stimuli to a heart at a demand-responsive adjusted pacing interval, said control device controlling the application of electrical stimuli to the heart, said control device calculating the adjusted pacing interval of the rate-responsive pacing, calculating an adjusted ventricular pace refractory period (VPRP_current) that is a function of said adjusted pacing interval, and calculating the end time of a T-wave monitoring window, said end time being a function of said adjusted pacing interval and being less than said VPRP_current.

16. The control device according to claim 15 wherein said control device also calculates the start time of a T-wave monitoring window.

17. The control device according to claim 16 wherein said start time is a function of said pacing interval and is less than said end time.

18. The control device according to claim 16 wherein said start time is a constant.

19. The control device according to claim 15 wherein said VPRP_current is proportional to the difference between a baseline pacing interval and the adjusted pacing interval.

20. The control device according to claim 15, further including a detector that detects signals that occur before said end time of said T-wave window.

21. The control device according to claim 20, further including an amplifier with an adjustable gain, wherein said gain is adjusted in response to changes in the amplitude of signals detected by said detector.

22. The device according to claim 15 wherein said end time is a function of said VPRP_current.

23. An implantable device for providing pacing and defibrillating stimuli to a heart, comprising:

a power source;

at least one electrode electrically connected to said power source;

a sensor capable of providing data that can be used to determine a physiological pacing demand; and

a control device, said control device controlling the application of electrical stimuli through said electrode, said control device calculating a physiological pacing demand based on said data, calculating an adjusted pacing interval based on said demand, calculating an adjusted ventricular pace refractory period (VPRP_current) that is a function of said pacing interval, and calculating the end time of a T-wave monitoring window, said end time being a function of said pacing interval and being less than said VPRP_current.